Impact BioMedical
IBO • XASE
Impact BioMedical is a pharmaceutical preparations company trading on XASE, led by CEO Frank D. Heuszel, with a market cap of $50.9M.
CEOFrank D. Heuszel
Next Earnings
Upcoming earnings announcement for Impact BioMedical
Date
Friday, February 20, 2026 (in 1 week)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 4 earnings reports for Impact BioMedical
10-Q